These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22645684)

  • 1. Easy method to examine single nerve fiber excitability and conduction parameters using intact nonanesthetized earthworms.
    Bähring R; Bauer CK
    Adv Physiol Educ; 2014 Sep; 38(3):253-64. PubMed ID: 25179616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teriflunomide for multiple sclerosis.
    He D; Xu Z; Dong S; Zhang H; Zhou H; Wang L; Zhang S
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009882. PubMed ID: 23235682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral nervous system in multiple sclerosis-understanding the involvement via autonomic nervous system.
    Adamec I; Krbot Skorić M; Habek M
    Neurol Sci; 2021 Jul; 42(7):2731-2736. PubMed ID: 34036450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strength-duration time constant in peripheral nerve: no abnormality in multiple sclerosis.
    Genç G; Bek S; Kasikci T; Ulas UH; Demirkaya S; Odabasi Z
    Mult Scler Int; 2012; 2012():390157. PubMed ID: 22645684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strength-duration properties of sensory and motor axons in alcoholic polyneuropathy.
    Yerdelen D; Koc F; Uysal H
    Neurol Res; 2008 Sep; 30(7):746-50. PubMed ID: 18489821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strength-duration properties in diabetic polyneuropathy.
    Yerdelen D; Koç F; Uysal H; Sarica Y
    Diabetes Res Clin Pract; 2007 Oct; 78(1):56-9. PubMed ID: 17408800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strength-duration time constant and rheobase measurements: Comparison of the threshold tracking method and a manual procedure.
    Tyberghein M; Janssen A; Wang FC
    Clin Neurophysiol; 2023 Oct; 154():27-33. PubMed ID: 37541074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of cortical neuronal strength-duration properties on TMS pulse shape.
    Menon P; Pavey N; Aberra AS; van den Bos MAJ; Wang R; Kiernan MC; Peterchev AV; Vucic S
    Clin Neurophysiol; 2023 Jun; 150():106-118. PubMed ID: 37060842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sex and age on strength-duration properties.
    Yerdelen D; Uysal H; Koc F; Sarica Y
    Clin Neurophysiol; 2006 Sep; 117(9):2069-72. PubMed ID: 16875875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
    Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
    Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic neurological channelopathies.
    Ryan DP; Ptácek LJ
    Neuron; 2010 Oct; 68(2):282-92. PubMed ID: 20955935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Kapoor R; Furby J; Hayton T; Smith KJ; Altmann DR; Brenner R; Chataway J; Hughes RA; Miller DH
    Lancet Neurol; 2010 Jul; 9(7):681-8. PubMed ID: 20621711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological channelopathies: new insights into disease mechanisms and ion channel function.
    Kullmann DM; Waxman SG
    J Physiol; 2010 Jun; 588(Pt 11):1823-7. PubMed ID: 20375141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological channelopathies.
    Kullmann DM
    Annu Rev Neurosci; 2010; 33():151-72. PubMed ID: 20331364
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.